in progress

Draft Research Plan

Sexually Transmitted Infections: Behavioral Counseling

January 16, 2025

Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

This document is available for Public Comments until Feb 12, 2025 11:59 PM EST

In an effort to maintain a high level of transparency in our methods, we open our Draft Research Plan to a public comment period before we publish the final version.

Leave a Comment >>

Figure 1 is the analytic framework that depicts the three Key Questions to be addressed in the systematic review. The figure illustrates how behavioral counseling interventions to decrease risky or increase protective sexual behaviors, or both, reduce sexually transmitted infections (STIs) or related morbidity and mortality (Key Question 1). In addition, the figure illustrates how behavioral counseling interventions lead to decreased risky or increased protective sexual behaviors that can reduce the risk of STIs (Key Question 2) as well as any related harms associated with these interventions (Key Question 3).

Abbreviations: STI=sexually transmitted infection; QoL=quality of life.

  1. Do behavioral counseling interventions that aim to decrease risky or increase protective sexual behaviors, or both, reduce sexually transmitted infections (STIs) or related morbidity and mortality?
  2. Do behavioral counseling interventions decrease risky or increase protective sexual behaviors that can reduce the risk of STIs?
  3. What potential harms are associated with behavioral counseling interventions to reduce STI infections?

Contextual questions will not be systematically reviewed and are not shown in the Analytic Framework.

  1. What clinical risk assessment tools or guidance can be used to help primary care clinicians identify individuals at higher risk for STIs?
  2. What social, structural, and health system factors in the United States contribute to inequities in STI risk, and how can they be addressed to improve sexual health outcomes?
  3. Are there STI behavioral counseling interventions or modalities that have been developed to address the needs and concerns of specific populations with regard to gender, sexual practices or orientation, race or ethnicity, disability status, or other characteristics?

Health equity will be considered throughout the review using several approaches. For key questions, we will describe the population characteristics of the included studies to assess the degree to which the evidence is representative of diverse populations. We will also analyze benefits and harms of treatment interventions by specific populations to the extent that this is reported in the included studies for selected populations of interest. These groups include racial and ethnic groups, socioeconomic and insurance status, or other social risk factors. Depending on the study design and timing of studies, descriptions of study populations vary in their recognition of the presence of transgender, gender nonbinary, and gender expansive individuals. We will generally use the gender terminology used to describe included study populations; however, since anatomic, social, and behavioral factors contribute to STI risk, we will aim to characterize gender as specifically as possible when information is available, including sex assigned at birth when reported (e.g., cisgender, transgender).

The proposed Research Approach identifies the study characteristics and criteria that the Evidence-based Practice Center will use to search for publications and to determine whether identified studies should be included or excluded from the Evidence Review. Criteria are overarching as well as specific to each of the key questions.

Category Included Excluded
Aim Studies targeting sexual behavior change to prevent STIs Studies aimed solely at targeting behavior change to prevent unintended pregnancy or to change behaviors associated with risky sexual behavior (e.g., substance use disorders, interpersonal violence)
Condition Any infection that is transmitted through sexual contact (i.e., oral, vaginal, or anal), including, but not limited to: HIV, human papillomavirus (HPV), herpes simplex virus (HSV) type 1 and 2, hepatitis B and C viruses, chlamydia, gonorrhea, syphilis, mpox, and trichomoniasis. Infections acquired through nonsexual transmission routes (e.g., maternal-fetal transmission, blood transfusions, inadvertent needle sticks, sharing needles or injection equipment with an infected person)
Population

Adolescents and adults, including pregnant individuals
Persons who are sexually active
Persons who have not yet become sexually active

Studies limited to populations requiring specialized healthcare or interventions to address STI health risks (e.g., HIV-positive individuals, commercial sex workers, persons who inject drugs)
Interventions

Interventions involving behavioral counseling to prevent or reduce STIs (i.e., some provision of education, skills training, or guidance on how to change sexual behaviors) delivered alone or in combination with other interventions intended to promote sexual health and risk reduction or risk avoidance, which can feasibly be implemented in or referred from primary care. Interventions may include, but are not limited to:

  • Individual-, family-, couple-, or group-based counseling (e.g., motivational interviewing, cognitive behavioral therapy)
  • Waiting room, multimedia, or other health system–based behavior change interventions
  • Telemedicine or technology-based behavior change interventions (e.g., text messages, Internet-based)

Trials within closed pre-existing social networks (e.g., worksite or church programs) or within schools
Social marketing (e.g., media campaigns)
Trials solely focused on biomedical prevention interventions (e.g., HPV vaccination, doxy PEP, PrEP for HIV)
STI testing only
Counseling to increase partner referral/notification only

 

Comparators

No intervention (e.g., waitlist)
Usual care
Minimal intervention (e.g., usual care limited to ≤15 minutes of information)
Attention control (e.g., similar in format and intensity but focused on a different content area, such as general sex education, wellness promotion, or nutrition education)

Active intervention (i.e., comparative effectiveness)
Outcomes KQ 1 (Health outcomes):
  • STI incidence (based on testing/biologic confirmation)
  • Mortality and quality of life
  • STI-related health outcomes, including cancers, reproductive complications, perinatal or neonatal morbidity/mortality, and mental health

KQ 2 (Behavioral outcomes):

  • Changes in protective behaviors (e.g., condom use, sexual abstinence)
  • Changes in STI risk behaviors (e.g., fewer sexual partners, avoiding sex while intoxicated with alcohol or other substances)

KQ 3 (Harms):

  • Increase in STI incidence or risky sexual behaviors or decrease in protective behaviors
  • Healthcare avoidance
  • Psychological harms
  • Self-reported measures of infection, attitude, knowledge, ability, or self-efficacy, including:
    • Knowledge of risks and protective behaviors
    • Perception of STI risk in self or partners
    • Perceived relationship power
    • Sexual negotiation skills
    • Scheduling a health care appointment
    • Intention to use protective barriers
    • Carrying barrier protection
Setting

Conducted in or recruited from primary care settings, including:

  • Healthcare systems
  • STI clinics
  • Family planning clinics
  • School-based health clinics
  • Prenatal care clinics
  • Military health clinics
  • Obstetrics-gynecology clinics
  • Behavioral/mental health clinics

Research laboratories
Correctional facilities
School classrooms
Worksites
Substance abuse treatment facilities or methadone maintenance clinics
Inpatient/residential facilities
Emergency departments

Study design Randomized, controlled trials and nonrandomized, controlled trials (controlled clinical trials) Observational studies; comparative effectiveness trials without a control group
Timing of outcome assessment ≥3 months post-baseline <3 months post-baseline
Publication date Published after 1999 (2000 to present) Published in or before 1999
Country Studies conducted in countries categorized as “Very High” on the 2023/2024 Human Development Index (as defined by the United Nations Development Programme) Countries with a Human Development Index other than “Very High”
Language English only Non-English publications
Study quality Fair or good-quality studies Poor-quality studies (according to design-specific USPSTF criteria)

Abbreviations: AIDS = acquired immunodeficiency syndrome; doxy PEP = doxycycline post-exposure prophylaxis; HIV = human immunodeficiency virus; HSV = herpes simplex virus; KQ = key question; PrEP = pre-exposure prophylaxis; STI = sexually transmitted infections; USPSTF = U.S. Preventive Services Task Force.